Name:
4-Methyl-2,5-dimethoxyamphetamine
Type:
Psychedelic phenethylamine
AKA:
DOM, STP
4-Methyl-2,5-dimethoxyamphetamine image
Synthetic substance, no natural derivative
IUPAC Logo
4-Methyl-2,5-dimethoxyamphetamine image
4-Methyl-2,5-dimethoxyamphetamine (DOM), also known as STP, is a psychedelic amphetamine developed in the 1960s by Alexander Shulgin. It became infamous during the 1967 Summer of Love in San Francisco for its long-lasting and intense effects. Though never widely used, DOM remains a substance of interest in the study of psychedelics and their effects on human consciousness.
Synthetic Substances Image
4-Methyl-2,5-dimethoxyamphetamine (4-MDMA), a synthetic stimulant, acts as an upper with stimulant and empathogenic effects. Short-term effects include increased heart rate, euphoria, and dilated pupils, while long-term use may cause neurotoxicity and memory issues. Overdose risks include hyperthermia and serotonin syndrome. Safe dosage is not well established; recent research highlights concerns over neurotoxic effects and the need for caution due to high abuse potential.
N/A
4-Methyl-2,5-dimethoxyamphetamine (4-MDMA) influences serotonin systems, causing altered perception and mood. Effects last 6-8 hours, with potential for long-term cognitive and mood disturbances with frequent use. Current research investigates its impact on mental health and therapeutic uses in controlled settings.
N/A
4-Methyl-2,5-dimethoxyamphetamine (DOM or STP) is a potent psychedelic that became popular in the 1960s counterculture. Known for its long-lasting effects, it was initially distributed as a recreational drug at music festivals and psychedelic gatherings. Its cultural impact is closely tied to the era’s experimentation with mind-altering substances, which aimed to expand consciousness and challenge societal norms. However, its unpredictability and the intensity of its effects led to numerous adverse reactions, causing concern among authorities and contributing to its eventual regulation. The substance remains a symbol of the 1960s' quest for expanded awareness and its associated risks.
N/A